B
ABMD

BP’s Abiomed Inc ABMD Stock Holding History

BP’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,181
Closed -$368K – 566
2021
Q2 		$368K Sell
1,181
-506
-30% -$155K 0.02% 494
2021
Q1 		$538K Sell
1,687
-533
-24% -$171K 0.02% 453
2020
Q4 		$720K Sell
2,220
-1,980
-47% -$548K 0.02% 413
2020
Q3 		$1.16M Sell
4,200
-300
-7% -$86.4K 0.03% 395
2020
Q2 		$1.09M Buy
+4,500
New +$904K 0.04% 408
2019
Q1 		– Sell
-4,700
Closed -$1.53M – 459
2018
Q4 		$1.53M Hold
4,700
– – 0.06% 296
2018
Q3 		$2.11M Buy
+4,700
New +$1.85M 0.06% 302

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

BP's ABMD Position: Q3 2021 in Review

BP sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 1,181 shares — an estimated $368K sold.

BP first reported a position in ABMD in Q3 2018 and held it in 7 quarters. The position peaked at $2.11M in Q3 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • BP reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • BP sold 1,181 Abiomed Inc shares in Q3 2021, an estimated $368K.
  • BP first reported a position in Abiomed Inc in Q3 2018 and held it in 7 quarters.
  • BP's Abiomed Inc position peaked at $2.11M in Q3 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.